Scott Brun

Dr. Scott Brun, MD, is an Independent Director at Cabaletta Bio, Inc., a President at Gold Mast Consulting, LLC, an Advisory Board at Accelerator Services Corp and a Venture Partner at Abingworth Management, Inc. He is on the Board of Directors at Cabaletta Bio, Inc., Vertero Therapeutics, Inc. and Trishula Therapeutics, Inc. Dr. Brun was previously employed as an Independent Director by Jasper Therapeutics, Inc., an Independent Director by Forte Biosciences, Inc., a Head-Clinical Development by Abbott Laboratories, and a Vice President & Head-AbbVie Ventures by AbbVie, Inc. He received his undergraduate degree from the University of Illinois At Urbana–Champaign and a doctorate degree from The Johns Hopkins University School of Medicine.